Garner (LON:GAR)

The Economic Times  Oct 14  Comment 
Significantly, of the 25 IPOs in the first half of the current financial year, 21 were from the Small and Medium Enterprise (SME) sector.
The Times of India  Oct 9  Comment 
Indian companies have mopped-up more than Rs 4,500 crore through issuing 'Rights' shares till August this year to meet working capital requirement.
NPR  Oct 8  Comment 
Several recent incidents of black men being shot by police have sparked national news coverage and policy debates. We examine what forces in the media and society are fueling this level of attention.
New York Times  Oct 7  Comment 
A claim maintains that the police were directly responsible for the death of Mr. Garner, who died after he was wrestled to the ground by officers arresting him.
Forbes  Sep 25  Comment 
Thumbnail: Starring Adam Sandler, Jennifer Garner, and Ansel Elgort, Jason Reitman's Internet-era cautionary tale works best as an ensemble character study even as it paints too simplistic a brush with too many of its characters for the sake of...
NPR  Sep 25  Comment 
When it comes to police using force, what is acceptable and when? And are police too aggressive? Cops say they're trying to survive, but reformers say aggressive cop culture is making things worse.
Benzinga  Sep 24  Comment 
CNBC Mad Money's Jim Cramer spoke on the show about the price movement in natural gas and he used technical analysis of Carley Garner to get a grip on a possible future price movement. Cramer said that the commodity has been getting absolutely...
SeekingAlpha  Sep 11  Comment 
By Don Dion: Affimed Therapeutics B.V. (Pending:AFMD), a clinical-stage biopharmaceutical company, engaged in the development of cancer immunotherapies, plans to raise $75 million in its upcoming IPO. The Heidelberg, Germany-based firm will offer...
The Hindu Business Line  Sep 10  Comment 
A turf war has once again broken out between Indonesia and Malaysia, two of the world’s top palm oil producers, to retain market share in the lucrative export business. The latest in the se...
Benzinga  Sep 10  Comment 
In a report published Wednesday, Sterne Agee analyst Shibani Malhotra reiterated a Buy rating and $272.00 price target on Actavis plc (NYSE: ACT). In the report, Sterne Agee noted, “Although Actavis failed to garner support at today's FDA...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki